^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

TheraCIM (nimotuzumab)

i
Company:
Biocon, Daiichi Sankyo, Oncoscience
Drug class:
EGFR inhibitor
Related drugs: